Based on our analysis, we may partially confirm the reactive vascular hypothesis of San Martin et al. [60], with the novelty of the present study being that this confirmation characterized HER2 and LB-HER2 BC subtypes only. This evidence concerns the gene ERBB2 and breast cancer.